Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies

Hsiao Han Liu, Kuan Hsuan Chen, Yi Ping Shih, Wing Yiu Lui, Fen Hwa Wong, Yi Ming A. Chen

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Glycine N-methyltransferase (GNMT) is a protein with multiple functions. Recently, two Italian siblings who had hepatomegaly and chronic elevation of serum transaminases were diagnosed to have GNMT deficiency caused by inherited compound heterozygosity of the GNMT gene with missence mutations. To evaluate the expression of GNMT in cell lines and tissues from hepatocellular carcinoma (HCC) patients, we produced two monoclonal antibodies (mAbs) 4-17 and 14-1 using two recombinant GNMT fusion proteins. M13 phage peptide display showed that the reactive epitopes of mAbs 4-17 and 14-1 were amino acid residues 11-15 and 272-276 of human GNMT, respectively. The dissociation constants of the binding between GNMT and mAbs were 1.7 × 10-8 M for mAb 4-17 and 1.8 × 10-9 M for mAb 14-1. Both mAbs can identify GNMT present in normal human and mouse liver tissues using Western blotting (WB) and immunohistochemical staining assay (IHC). In addition, WB with both mAbs showed that none of 2 hepatoblastoma and 5 HCC cell lines expressed GNMT. IHC demonstrated that 50% (13/26) of nontumorous liver tissues and 96% (24/25) of HCC tissues did not express GNMT. Therefore, the expression of GNMT was downregulated in human HCC.

Original languageEnglish
Pages (from-to)87-97
Number of pages11
JournalJournal of Biomedical Science
Volume10
Issue number1
DOIs
Publication statusPublished - Feb 13 2003
Externally publishedYes

Fingerprint

Glycine N-Methyltransferase
Monoclonal Antibodies
Tissue
Liver
Hepatocellular Carcinoma
Western Blotting
Bacteriophage M13
Hepatoblastoma
Cells
Cell Line
Hepatomegaly
Bacteriophages
Transaminases
Siblings
Epitopes
Proteins
Down-Regulation

Keywords

  • Epitope mapping
  • Glycine N-methyltransferase
  • Hepatocellular carcinoma
  • Monoclonal antibody
  • Recombinant protein

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology
  • Biochemistry, medical
  • Pharmacology (medical)

Cite this

Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies. / Liu, Hsiao Han; Chen, Kuan Hsuan; Shih, Yi Ping; Lui, Wing Yiu; Wong, Fen Hwa; Chen, Yi Ming A.

In: Journal of Biomedical Science, Vol. 10, No. 1, 13.02.2003, p. 87-97.

Research output: Contribution to journalArticle

@article{9a1f5c62140a41f1bf4c2b184f93ae54,
title = "Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies",
abstract = "Glycine N-methyltransferase (GNMT) is a protein with multiple functions. Recently, two Italian siblings who had hepatomegaly and chronic elevation of serum transaminases were diagnosed to have GNMT deficiency caused by inherited compound heterozygosity of the GNMT gene with missence mutations. To evaluate the expression of GNMT in cell lines and tissues from hepatocellular carcinoma (HCC) patients, we produced two monoclonal antibodies (mAbs) 4-17 and 14-1 using two recombinant GNMT fusion proteins. M13 phage peptide display showed that the reactive epitopes of mAbs 4-17 and 14-1 were amino acid residues 11-15 and 272-276 of human GNMT, respectively. The dissociation constants of the binding between GNMT and mAbs were 1.7 × 10-8 M for mAb 4-17 and 1.8 × 10-9 M for mAb 14-1. Both mAbs can identify GNMT present in normal human and mouse liver tissues using Western blotting (WB) and immunohistochemical staining assay (IHC). In addition, WB with both mAbs showed that none of 2 hepatoblastoma and 5 HCC cell lines expressed GNMT. IHC demonstrated that 50{\%} (13/26) of nontumorous liver tissues and 96{\%} (24/25) of HCC tissues did not express GNMT. Therefore, the expression of GNMT was downregulated in human HCC.",
keywords = "Epitope mapping, Glycine N-methyltransferase, Hepatocellular carcinoma, Monoclonal antibody, Recombinant protein",
author = "Liu, {Hsiao Han} and Chen, {Kuan Hsuan} and Shih, {Yi Ping} and Lui, {Wing Yiu} and Wong, {Fen Hwa} and Chen, {Yi Ming A.}",
year = "2003",
month = "2",
day = "13",
doi = "10.1159/000068083",
language = "English",
volume = "10",
pages = "87--97",
journal = "Journal of Biomedical Science",
issn = "1021-7770",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies

AU - Liu, Hsiao Han

AU - Chen, Kuan Hsuan

AU - Shih, Yi Ping

AU - Lui, Wing Yiu

AU - Wong, Fen Hwa

AU - Chen, Yi Ming A.

PY - 2003/2/13

Y1 - 2003/2/13

N2 - Glycine N-methyltransferase (GNMT) is a protein with multiple functions. Recently, two Italian siblings who had hepatomegaly and chronic elevation of serum transaminases were diagnosed to have GNMT deficiency caused by inherited compound heterozygosity of the GNMT gene with missence mutations. To evaluate the expression of GNMT in cell lines and tissues from hepatocellular carcinoma (HCC) patients, we produced two monoclonal antibodies (mAbs) 4-17 and 14-1 using two recombinant GNMT fusion proteins. M13 phage peptide display showed that the reactive epitopes of mAbs 4-17 and 14-1 were amino acid residues 11-15 and 272-276 of human GNMT, respectively. The dissociation constants of the binding between GNMT and mAbs were 1.7 × 10-8 M for mAb 4-17 and 1.8 × 10-9 M for mAb 14-1. Both mAbs can identify GNMT present in normal human and mouse liver tissues using Western blotting (WB) and immunohistochemical staining assay (IHC). In addition, WB with both mAbs showed that none of 2 hepatoblastoma and 5 HCC cell lines expressed GNMT. IHC demonstrated that 50% (13/26) of nontumorous liver tissues and 96% (24/25) of HCC tissues did not express GNMT. Therefore, the expression of GNMT was downregulated in human HCC.

AB - Glycine N-methyltransferase (GNMT) is a protein with multiple functions. Recently, two Italian siblings who had hepatomegaly and chronic elevation of serum transaminases were diagnosed to have GNMT deficiency caused by inherited compound heterozygosity of the GNMT gene with missence mutations. To evaluate the expression of GNMT in cell lines and tissues from hepatocellular carcinoma (HCC) patients, we produced two monoclonal antibodies (mAbs) 4-17 and 14-1 using two recombinant GNMT fusion proteins. M13 phage peptide display showed that the reactive epitopes of mAbs 4-17 and 14-1 were amino acid residues 11-15 and 272-276 of human GNMT, respectively. The dissociation constants of the binding between GNMT and mAbs were 1.7 × 10-8 M for mAb 4-17 and 1.8 × 10-9 M for mAb 14-1. Both mAbs can identify GNMT present in normal human and mouse liver tissues using Western blotting (WB) and immunohistochemical staining assay (IHC). In addition, WB with both mAbs showed that none of 2 hepatoblastoma and 5 HCC cell lines expressed GNMT. IHC demonstrated that 50% (13/26) of nontumorous liver tissues and 96% (24/25) of HCC tissues did not express GNMT. Therefore, the expression of GNMT was downregulated in human HCC.

KW - Epitope mapping

KW - Glycine N-methyltransferase

KW - Hepatocellular carcinoma

KW - Monoclonal antibody

KW - Recombinant protein

UR - http://www.scopus.com/inward/record.url?scp=0037261378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037261378&partnerID=8YFLogxK

U2 - 10.1159/000068083

DO - 10.1159/000068083

M3 - Article

VL - 10

SP - 87

EP - 97

JO - Journal of Biomedical Science

JF - Journal of Biomedical Science

SN - 1021-7770

IS - 1

ER -